주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-19 17:10 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
1,792 )
기사목록 보기 형태
제목형
요약형
포토형
BeiGene’s Brukinsa quickly passes HIRA’s reimbursement review
Kim Yun-mi
2022.04.07 11:50
Processa begins US trial of gastrointestinal drug Yuhan licensed out
Kim Chan-hyuk
2022.04.06 18:05
Humedix, Exostemtech to co-develop exosome-based treatments
Lee Han-soo
2022.04.06 18:02
Top court sides with Hugel to allow making and selling of BTX products
Lee Han-soo
2022.04.06 18:01
Boehringer Ingelheim aims to release 15 new drugs by 2025
Kim Yun-mi
2022.04.06 12:03
Foreign investors dump shares of Korea United Pharm
Kim Chan-hyuk
2022.04.06 12:02
‘Therapeutic cancer vaccines emerging as candidates for combo therapy’
Kim Chan-hyuk
2022.04.05 16:59
Medytox ends P3 study for next-generation botulinum toxin
Lee Han-soo
2022.04.05 16:57
SK Chemicals to co-market UCB's epilepsy treatment
Lee Han-soo
2022.04.04 15:49
MSD faces delay of pneumococcal vaccine indication for pediatric population
Kim Yun-mi
2022.04.04 12:06
Daewon Pharm launches gastroesophageal reflux therapy
Lee Han-soo
2022.04.04 12:03
Handok to exclusively supply and distribute Incyte's anticancer treatment
Lee Han-soo
2022.04.01 17:14
처음
이전
이전
이전
141
142
143
144
145
146
147
148
149
150
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기